Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Journal of Pharmacological and Toxicological Methods|September 20, 2005
Measurement of 5-HT4 receptor-mediated esophageal responses by digital sonomicrometry in the anesthetized ratScott R Armstrong, Julia L McCullough, David T BeattieNaunyn-Schmiedeberg'S Archives of Pharmacology|April 4, 2013
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonistPamela R Tsuruda, Ross G Vickery, Daniel D Long, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|September 9, 2011
The inability of tegaserod to affect platelet aggregation and coronary artery tone at supratherapeutic concentrationsDeborah L Higgins, Mike P Ero, Michelle Loeb, et al.Journal of Bacteriology|February 17, 2009
Functional genomics of Enterococcus faecalis: multiple novel genetic determinants for biofilm formation in the core genomeKatie S Ballering, Christopher J Kristich, Suzanne M Grindle, et al.ACS Omega|August 5, 2024
Bioluminescent Assay for the Quantification of Cellular Glycogen LevelsDonna Leippe, Rebeca Choy, Gediminas Vidugiris, et al.Neuropharmacology|March 12, 2011
5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessmentFei Shen, Jacqueline A M Smith, Ray Chang, et al.Journal of Inflammation (London, England)|December 12, 2017
Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapyDavid T Beattie, M Teresa Pulido-Rios, Fei Shen, et al.Anesthesiology|April 26, 2012
AZD-3043: a novel, metabolically labile sedative-hypnotic agent with rapid and predictable emergence from hypnosisTalmage D Egan, Shinju Obara, Thomas E Jenkins, et al.Bioorganic & Medicinal Chemistry Letters|May 14, 2017
Discovery of N-substituted-endo-3-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol and -phenyl carboxamide series of μ-opioid receptor antagonistsLan Jiang, David T Beattie, John R Jacobsen, et al.Bioorganic & Medicinal Chemistry Letters|June 13, 2013
Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic propertiesR Murray McKinnell, Scott R Armstrong, David T Beattie, et al.Pageof 2